JPH06123079A - Yarn containing drug effect component and its production - Google Patents

Abstract

PURPOSE:To prepare a yarn containing a drug effect component, free from considerable lowering of the effect after washing, etc., and having long life and to provide a process for producing the yarn. CONSTITUTION:A solution or emulsion containing an extract composed of an effective natural drug-effect component of vegetable or animal source is sealed in an inorganic porous microcapsule vessel and the microcapsules are nearly uniformly mixed in raw fibers such as raw wool and raw cotton and the fiber containing the microcapsules are spun to form the objective yarn.

Description

Detailed Description of the Invention

[0001]

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a yarn in which a medicinal component such as a crude drug or a plant extract component is mixed in a yarn spinning stage, and a method for producing the yarn.

[0002]

2. Description of the Related Art It has been conventionally known that plant extract components represented by crude drugs have various medicinal effects. And
In order to utilize these medicinal effects, especially deodorant, antibacterial, moisturizing, and insect repellent and pest repellent effects in clothes such as underwear, a technique for adhering them to a cloth has been developed. For example, there is known a structure in which the extraction dilution liquid of hinokitiol is applied to a fabric as it is, impregnated in fibers, or kneaded with a binder and applied to the surface.

[0003]

However, these conventional techniques have a problem in that the manufacturing technique is relatively simple, but the useful life of the drug is short. That is, it is indispensable to wash in the case of clothing, but when applied or impregnated on the surface of the cloth, most of the effective ingredients are washed off by one wash, and the proper condition is maintained. I can't keep up. Further, even when kneading with a binder, the result is slightly better than that of the above technique, and there is no great difference. Especially when using a binder, its components are limited because it comes into direct contact with the skin, but if it is a natural ingredient glue that does not adversely affect the skin, there is also the problem that it will be washed out several times. is there.

Further, if the extracted component is volatile, the active component has already volatilized when the user obtains it,
There is also a fatal problem that it cannot exhibit sufficient performance.

The present invention solves the problems of these conventional products, and an object of the present invention is to provide a medicinal ingredient-containing yarn having a long useful life and a method for producing the yarn which has a long-lasting effect and does not extremely deteriorate in efficacy. To do.

[0006]

In order to achieve the above-mentioned object, the present invention encloses a solution or emulsion containing an extract consisting of active natural medicinal ingredients of plant and animal origin in an inorganic porous microcapsule container. The composition of the medicinal ingredient-containing yarn spun after mixing the microcapsules with the fibrils such as fluff or cotton almost uniformly, and the manufacturing method thereof are disclosed.

[0007]

[Action] The natural active ingredients of botanical or animal origin are
It has the function of maintaining the normal state of various human bodies by using them alone or in combination. It is not necessary to intentionally specify these medicinal components, and a combination that exerts a desired efficacy is adopted. The microcapsule container has a function of encapsulating a selected medicinal component, forms a strong shell body by using an inorganic porous material, and acts to gently leach the medicinal component. The microcapsules having these functions are woven into the yarn by spinning to complete the raw yarn exhibiting the desired effect.

[0008]

EXAMPLES Examples of the present invention will be described below. First, the effective natural drug components used in the present invention are listed below.
The plant components and tree components are as follows. Hinokitiol extract Essential oils containing hinokitiol Various oils containing phytoncide Eucalyptus oil Extracts of hardwoods such as cypress, pine and cedar, broadleaf trees such as birch and bodhi peppermint Extracts of citrus fruits Extracts of ginseng and mugwort Extracts of ginseng Vegetable oils such as rice germ oil, etc., and other extracts of the lily family, rose family, camellia family Hachima, capsicum, horseradish, garlic, gymnema, matatabi, morohaya, pearl barley, carrot, tomato, aloe, loquat, peach, licorice, purple root, hop , Evening primrose, apples, lettuce, herbs such as rosemary dokudami thyme parsley, horsetail, cucumber, linseed tea, ages, life-prolonging grass, yellow oak, hypericum, various seaweeds, kujin, kumazasa, brown sugar, gentian, genosho,
Burdock, hawthorn, hawthorn, shiitake mushroom, dio, perilla,
Red oyster, ginger, iris, senkyu, senburi, mulberry bark, rind, touki, orange peel, juniper, bakuryu, safflower, matsukasa, yukinoshita,
The extract animal ingredients such as citron, litchi, chamomile, salvia, comfrey, henna, lavender and peony are as follows. As for the royal jelly, propolis, musk oil and horse oil extraction methods, known extraction methods suitable for each component are adopted.

First, one having a desired medicinal component is selected from these components, and the extract or oil is used alone or in combination. The components thus determined remain undiluted according to their properties, or as an aqueous solution with a suitable dilution rate using water as a solvent, or an alcohol solution with a suitable dilution rate using alcohol as a solvent, and further emulsified Emulsion. Then, these are enclosed in a microcapsule container to manufacture a drug-containing microcapsule. Here, as a material of the microcapsule container, for example, a microcapsule obtained by making an inorganic material typified by silica porous by an interfacial reaction method is used. Since the raw material of this microcapsule is silica or the like, it has high strength as a shell and is not easily broken by an external force. Therefore, it is possible to sufficiently withstand the subsequent manufacturing steps such as spinning, friction during use, and even washing. Some microcapsules are organic products that are petroleum products, but they are not suitable for the present invention because they have low strength and are easily broken. In addition, organic microcapsules are intended to completely enclose the contents, and the property of the contents is exhibited only after being destroyed. Therefore, it is inconsistent with the usage of the present invention in that it does not exert its effect when the clothing is worn and the content easily flows out during washing. In addition, since organic microcapsules are vulnerable to heat, they may be destroyed during fiber processing, which is not preferable in any case. The emulsion may be used as it is without being microencapsulated depending on the properties of the drug.

Next, a large amount of the microcapsules produced as described above are uniformly mixed with the fibrils before spinning.
The mixing ratio varies somewhat depending on the medicinal components, but the distribution can be selected as appropriate. Here, the fibril does not mean only the wool fiber and the cotton fiber,
It includes all fibers suitable for spinning, such as silk fibers, hemp fibers, or synthetic fibers.

Further, the thus-produced microcapsule-blended fibrils are spun to produce the yarn of the present invention. There is no particular change in the spinning method, and it is sufficient to adopt a known method. Microfibers are woven uniformly and in a large amount in the yarn spun in this manner, and since they are also fixed inside the yarn, they do not easily disappear. In addition, since the material of the microcapsule container as the shell is an inorganic material such as silica having high strength, it is not destroyed during spinning. It should be noted that it is free to knead an appropriate binder when mixing the fibrils with the microcapsules so that the microcapsules located near the surface of the yarn do not easily fall off.

When the undergarment sewn with the cloth using the yarn of the present invention is worn, the contents gently exude from the porous surface of the microcapsules by absorbing sweat and moisture in the atmosphere, The medicinal component is gradually absorbed through the skin and exerts a desired effect. In addition, since the microcapsules are firmly spun into the raw yarn, they do not easily flow out even during washing and have a very long medicinal life. As an example, the one using the coix seed extract was worn according to the usual usage and washed at a normal frequency, but it can maintain a life of about 5 to 10 times as long as that according to the conventional application method. did it. As a next example, a tomato extract and a carrot extract were tested under the same conditions as those of the above-mentioned examples, but almost the same life could be maintained.

[0013]

INDUSTRIAL APPLICABILITY According to the present invention, when producing a yarn, a solution or emulsion containing an extract consisting of active plant and animal natural medicinal ingredients is enclosed in an inorganic porous microcapsule container, Is mixed almost uniformly with fibrils such as wool or cotton, and spinning is performed in this state, so microcapsules are woven into the yarn almost evenly, exhibiting an average drug effect and providing a long-lived drug effect. We were able to. Moreover, since the microcapsule container employs an inorganic porous material, it is not easily destroyed during spinning or manufacturing of the fabric, and the medicinal component is gently leached from the porous surface, which is very good. It has become possible to maintain the condition.

Claims (2)

[Claims] 1. A solution or emulsion containing an extract consisting of active natural medicinal ingredients of plant and animal origin is enclosed in an inorganic porous microcapsule container, and the microcapsules are almost evenly distributed on fibrils such as wool or cotton. A yarn mixed with medicinal ingredients, which is spun after being mixed with. 2. A solution or emulsion containing an extract consisting of active natural medicinal ingredients of plant and animal origin is enclosed in an inorganic porous microcapsule container, and the microcapsules are almost evenly distributed on fibrils such as fluff or cotton. A method for producing a yarn containing a medicinal component, which comprises spinning the fibrils after mixing them with.